PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498770
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498770
Respiratory Tract Infection Treatment Market, By Infection Type, By Drug Class, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Respiratory Tract Infection Treatment Market size was valued at USD 43,290.32 Million in 2023, expanding at a CAGR of 6.10% from 2024 to 2032.
The Respiratory Tract Infection Treatment Market, encompassing therapies and medications for ailments affecting the respiratory system, is poised for significant growth driven by the rising prevalence of respiratory diseases, increasing air pollution, and the growing geriatric population. Key driving factors include advancements in diagnostic technologies, increased healthcare expenditure, and heightened awareness of respiratory health. However, the market faces restraints such as stringent regulatory frameworks and potential side effects of treatments. Opportunities abound in the form of emerging markets, innovative drug development, and increasing adoption of telemedicine and personalized medicine, which are expected to enhance treatment efficacy and accessibility.
Respiratory Tract Infection Treatment Market- Market Dynamics
High Prevalence of Respiratory Tract Infections Among Children Fuels Need of the Respiratory Tract Infection Treatment Market
The high prevalence of respiratory tract infections (RTIs) among children is significantly fueling the need for effective treatments in the Respiratory Tract Infection Treatment Market. According to the World Health Organization (WHO), acute respiratory infections (ARIs) are a leading cause of death in children under five years old, accounting for approximately 20% of all deaths in this age group globally. The Centers for Disease Control and Prevention (CDC) report that millions of children are affected by respiratory infections such as pneumonia and bronchitis each year, often requiring medical intervention. This growing burden underscores the urgent need for advanced treatment options, driving demand in the market as healthcare providers and parents seek effective solutions to combat these infections and reduce associated health complications.
Respiratory Tract Infection Treatment Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.10% over the forecast period (2024-2032)
Based on Infection Type segmentation, Lower Respiratory Tract Infections was predicted to show maximum market share in the year 2023
Based on Drug Class segmentation, Antibiotics was the leading type in 2023
Based on Route of Administration segmentation, Oral was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Respiratory Tract Infection Treatment Market- Segmentation Analysis:
The Global Respiratory Tract Infection Treatment Market is segmented on the basis of Infection Type, Drug Class, Route of Administration, End-User, and Region.
The market is divided into two categories based on Infection Type: Upper Respiratory Tract Infections, and Lower Respiratory Tract Infections. The upper Respiratory Tract Infections (URTI) segment is anticipated to dominate the market, driven by the high incidence of conditions such as common cold, sinusitis, and pharyngitis. Meanwhile, Lower Respiratory Tract Infections (LRTI) are expected to witness substantial growth due to factors including the rising prevalence of pneumonia and bronchitis, particularly among vulnerable populations.
The market is divided into five categories based on Drug Class: Antibiotics, Antiviral Drugs, Antifungal Drugs, Corticosteroids, and Bronchodilators. Antibiotics are expected to lead in market share, driven by their widespread use in treating respiratory infections caused by bacteria. Antiviral drugs are projected to follow, especially with advancements in treating viral respiratory infections like influenza. Meanwhile, corticosteroids, antifungal drugs, and bronchodilators are anticipated to have lower shares, tailored to specific respiratory conditions and patient needs.
Respiratory Tract Infection Treatment Market- Geographical Insights
North America leading in market share due to the high prevalence of respiratory diseases, well-established healthcare infrastructure, and strong emphasis on research and development activities. Europe follows suit, driven by increasing healthcare expenditure, favorable reimbursement policies, and a growing geriatric population prone to respiratory ailments. The Asia Pacific region is poised for significant growth, fueled by rapid urbanization, rising pollution levels, and increasing awareness of respiratory health. The region's large population base and expanding middle class also contribute to greater demand for respiratory tract infection treatments. Emerging economies in Latin America and the Middle East & Africa regions are also witnessing notable growth, propelled by improving healthcare access, rising disposable incomes, and government initiatives to enhance healthcare infrastructure. Market players strategically focus on these regions to capitalize on untapped opportunities and establish a strong foothold.
Respiratory Tract Infection Treatment Market- Competitive Landscape:
Major players in the market include pharmaceutical companies such as GlaxoSmithKline plc, Novartis AG, Pfizer Inc., AstraZeneca plc, and Sanofi S.A. These companies focus on developing innovative treatments, expanding their product portfolios, and strengthening their distribution networks to enhance market presence. Market players also invest significantly in research and development to introduce novel therapeutics and improve existing treatment options, catering to the evolving needs of healthcare providers and patients. Moreover, strategic alliances with healthcare organizations, academic institutions, and government bodies are increasingly being forged to leverage expertise, resources, and regulatory support. With the growing demand for effective respiratory tract infection treatments worldwide, competition among market players is expected to intensify, leading to ongoing innovations and advancements in the field.
Recent Developments:
In July 2023, the FDA approved Beyfortus (nirsevimab-alip) jointly developed by Sanofi and AstraZeneca. It's a monoclonal antibody designed to prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants and children under 24 months with a single intramuscular injection.
In May 2023, the FDA approved Arexvy, the inaugural RSV vaccine by GlaxoSmithKline Biologicals, for use in the United States. Arexvy is specifically indicated to prevent respiratory syncytial virus (RSV) and lower respiratory tract disease in individuals aged 60 and above.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RESPIRATORY TRACT INFECTION TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
AbbVie Inc.
AstraZeneca plc
Bayer AG
Boehringer Ingelheim International GmbH
Cipla Limited
F. Hoffmann-La Roche AG
Gilead Sciences, Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V. (now part of Viatris Inc.)
Novartis AG
Pfizer Inc.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Others
GLOBAL RESPIRATORY TRACT INFECTION TREATMENT MARKET, BY INFECTION TYPE- MARKET ANALYSIS, 2019 - 2032
- Upper Respiratory Tract Infections (URTI)
- Lower Respiratory Tract Infections (LRTI)
GLOBAL RESPIRATORY TRACT INFECTION TREATMENT MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019 - 2032
- Antibiotics
- Antiviral Drugs
- Antifungal Drugs
- Corticosteroids
- Bronchodilators
- Others
GLOBAL RESPIRATORY TRACT INFECTION TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
- Oral
- Injectable
- Inhalation
- Topical
GLOBAL RESPIRATORY TRACT INFECTION TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Homecare Settings
GLOBAL RESPIRATORY TRACT INFECTION TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Respiratory Tract Infection Treatment Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Respiratory Tract Infection Treatment Market Snippet by Infection Type
- 2.1.2. Respiratory Tract Infection Treatment Market Snippet by Drug Class
- 2.1.3. Respiratory Tract Infection Treatment Market Snippet by Route of Administration
- 2.1.4. Respiratory Tract Infection Treatment Market Snippet by End-User
- 2.1.5. Respiratory Tract Infection Treatment Market Snippet by Country
- 2.1.6. Respiratory Tract Infection Treatment Market Snippet by Region
- 2.2. Competitive Insights
3. Respiratory Tract Infection Treatment Key Market Trends
- 3.1. Respiratory Tract Infection Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Respiratory Tract Infection Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Respiratory Tract Infection Treatment Market Opportunities
- 3.4. Respiratory Tract Infection Treatment Market Future Trends
4. Respiratory Tract Infection Treatment Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Respiratory Tract Infection Treatment Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Respiratory Tract Infection Treatment Market Landscape
- 6.1. Respiratory Tract Infection Treatment Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Respiratory Tract Infection Treatment Market - By Infection Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Infection Type, 2023 & 2032 (%)
- 7.1.2. Upper Respiratory Tract Infections (URTI)
- 7.1.3. Lower Respiratory Tract Infections (LRTI)
8. Respiratory Tract Infection Treatment Market - By Drug Class
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Drug Class, 2023 & 2032 (%)
- 8.1.2. Antibiotics
- 8.1.3. Antiviral Drugs
- 8.1.4. Antifungal Drugs
- 8.1.5. Corticosteroids
- 8.1.6. Bronchodilators
- 8.1.7. Others
9. Respiratory Tract Infection Treatment Market - By Route of Administration
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
- 9.1.2. Oral
- 9.1.3. Injectable
- 9.1.4. Inhalation
- 9.1.5. Topical
10. Respiratory Tract Infection Treatment Market - By End-User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Clinics
- 10.1.4. Ambulatory Surgical Centers
- 10.1.5. Homecare Settings
11. Respiratory Tract Infection Treatment Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Respiratory Tract Infection Treatment Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Respiratory Tract Infection Treatment Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. Italy Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.9.4. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. United Kingdom Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.10.4. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. France
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. France Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.11.4. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.11.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
- 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.2. Russia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.12.3. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
- 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.2. Netherlands Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.13.3. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.2. Sweden Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
- 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.2. Poland Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.15.3. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Rest of the Europe Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.3.16.4. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Respiratory Tract Infection Treatment Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. India
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. India Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.8.4. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.8.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. China Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.9.4. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.9.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Thailand Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.13.4. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Indonesia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.14.4. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Respiratory Tract Infection Treatment Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Respiratory Tract Infection Treatment Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Respiratory Tract Infection Treatment Industry
- 12.1. Competitive Dashboard
- 12.2. Company Profiles
- 12.2.1. AbbVie Inc.
- 12.2.2. AstraZeneca plc
- 12.2.3. Bayer AG
- 12.2.4. Boehringer Ingelheim International GmbH
- 12.2.5. Cipla Limited
- 12.2.6. F. Hoffmann-La Roche AG
- 12.2.7. Gilead Sciences, Inc.
- 12.2.8. GlaxoSmithKline plc
- 12.2.9. Johnson & Johnson
- 12.2.10. Merck & Co., Inc.
- 12.2.11. Mylan N.V. (now part of Viatris Inc.)
- 12.2.12. Novartis AG
- 12.2.13. Pfizer Inc.
- 12.2.14. Sanofi S.A.
- 12.2.15. Sun Pharmaceutical Industries Ltd.
- 12.2.16. Teva Pharmaceutical Industries Ltd.
- 12.2.17. Others
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Respiratory Tract Infection Treatment Market: Infection Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Infection Type
- TABLE Global Respiratory Tract Infection Treatment Market, by Infection Type 2019-2032 (USD Million)
- TABLE Respiratory Tract Infection Treatment Market: Drug Class Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Drug Class
- TABLE Global Respiratory Tract Infection Treatment Market, by Drug Class 2019-2032 (USD Million)
- TABLE Respiratory Tract Infection Treatment Market: Route of Administration Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Route of Administration
- TABLE Global Respiratory Tract Infection Treatment Market, by Route of Administration 2019-2032 (USD Million)
- TABLE Respiratory Tract Infection Treatment Market: End-User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End-User
- TABLE Global Respiratory Tract Infection Treatment Market, by End-User 2019-2032 (USD Million)
- TABLE Respiratory Tract Infection Treatment Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Respiratory Tract Infection Treatment Market, by Region 2019-2032 (USD Million)
- TABLE North America Respiratory Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
- TABLE North America Respiratory Tract Infection Treatment Market, by Infection Type, 2019-2032 (USD Million)
- TABLE North America Respiratory Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
- TABLE North America Respiratory Tract Infection Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE North America Respiratory Tract Infection Treatment Market, by End-User, 2019-2032 (USD Million)
- TABLE Europe Respiratory Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Respiratory Tract Infection Treatment Market, by Infection Type, 2019-2032 (USD Million)
- TABLE Europe Respiratory Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
- TABLE Europe Respiratory Tract Infection Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE Europe Respiratory Tract Infection Treatment Market, by End-User, 2019-2032 (USD Million)
- TABLE Asia Pacific Respiratory Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Respiratory Tract Infection Treatment Market, by Infection Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Respiratory Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
- TABLE Asia Pacific Respiratory Tract Infection Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE Asia Pacific Respiratory Tract Infection Treatment Market, by End-User, 2019-2032 (USD Million)
- TABLE Latin America Respiratory Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Respiratory Tract Infection Treatment Market, by Infection Type, 2019-2032 (USD Million)
- TABLE Latin America Respiratory Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
- TABLE Latin America Respiratory Tract Infection Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE Latin America Respiratory Tract Infection Treatment Market, by End-User, 2019-2032 (USD Million)
- TABLE Middle East and Africa Respiratory Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Respiratory Tract Infection Treatment Market, by Infection Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Respiratory Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
- TABLE Middle East and Africa Respiratory Tract Infection Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- TABLE Middle East and Africa Respiratory Tract Infection Treatment Market, by End-User, 2019-2032 (USD Million)
